Skip to main content

Dr. Johnson L. Moon, M.D.

Neurology (Neurology Physician)

  • Medicare participating

At a glance

Years since graduation
24
In the NPI registry since
2007
Medicare patients seen, 2024
433

Licensed in California since 2004, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2002Medical school: University of Iowa, Rj & L Carver College of Medicine
  • 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Neurology Physician primary
    CA license A86444 (first issued 2004; current)
  • Clinical Neurophysiology Physician
    CA license A86444 (first issued 2004; current)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Neurology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
433
Services billed
979
Patients’ average age
77
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes391236
New patient office or other outpatient visit, 45-59 minutes132132
Measurement of brain wave activity (eeg), awake and asleep5050
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes4834
Measurement of brain wave activity (eeg), awake and drowsy4744
Critical care, first 30-74 minutes4228
Needle measurement of electrical activity in arm or leg muscles, complete study4023
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes3232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes2316
Established patient office or other outpatient visit, 20-29 minutes2020

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 11 companies reported 34 payments worth $864 in total to this clinician.

By company
AbbVie Inc.$251
Abbott Laboratories$191
Celgene Corporation$90.88
Novartis Pharmaceuticals Corporation$88.64
UCB, Inc.$66.80
Merz Pharmaceuticals, LLC$57.99
Csl Behring$35.72
Pfizer Inc.$26.02
By type
Food and Beverage$864

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in California →

Industry-funded research

Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $272,148 in research payments for these studies, mostly to the institutions running them.

  • A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (Targe…
    E.r. Squibb & Sons, L.l.c.
  • A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK)
    Janssen Research & Development, LLC

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Neurology clinicians in Fullerton

Sources

NPI registry (CMS NPPES, November 2026; record last updated July 8, 2011), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1457407579. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.